Literature DB >> 32378648

Rapid review for the anti-coronavirus effect of remdesivir.

Ziyi Li1, Xiaojie Wang1, Donglin Cao2, Ruilin Sun3, Cheng Li4, Guowei Li1,5.   

Abstract

The outbreak of SARS-CoV-2 rapidly spread across China and worldwide. Remdesivir had been proposed as a promising option for treating coronavirus disease 2019 (COVID-19). We provided a rapid review to critically assess the potential anti-coronavirus effect of remdesivir on COVID-19 and other coronaviruses based on the most up-to-date evidence. Even though remdesivir was proposed as a promising option for treating COVID-19 based on laboratory experiments and reports from compassionate use, its safety and effect in humans requires high-quality evidence from well-designed and adequately-powered clinical trials for further clarification.

Entities:  

Keywords:  COVID-19; SARS-CoV-2; effect; remdesivir; safety

Year:  2020        PMID： 32378648     DOI： 10.5582/ddt.2020.01015

Source DB:  PubMed          Journal:  Drug Discov Ther        ISSN： 1881-7831


  18 in total

Review 1.  Severity and Mortality Associated with Steroid Use among Patients with COVID-19: A Systematic Review and Meta-Analysis.

Authors:  Tamiru Sahilu; Tadesse Sheleme; Tsegaye Melaku
Journal:  Interdiscip Perspect Infect Dis       Date:  2021-05-06

Review 2.  COVID-19 and the elderly: insights into pathogenesis and clinical decision-making.

Authors:  Fabio Perrotta; Graziamaria Corbi; Grazia Mazzeo; Matilde Boccia; Luigi Aronne; Vito D'Agnano; Klara Komici; Gennaro Mazzarella; Roberto Parrella; Andrea Bianco
Journal:  Aging Clin Exp Res       Date:  2020-06-16       Impact factor: 3.636

3.  Reverse C-glycosidase reaction provides C-nucleotide building blocks of xenobiotic nucleic acids.

Authors:  Martin Pfeiffer; Bernd Nidetzky
Journal:  Nat Commun       Date:  2020-12-08       Impact factor: 14.919

4.  Prevalence of multidrug-, extensive drug-, and pandrug-resistant commensal Escherichia coli isolated from healthy humans in community settings in low- and middle-income countries: a systematic review and meta-analysis.

Authors:  Nana Adoma Nkansa-Gyamfi; Joseph Kazibwe; Daouda A K Traore; Emmanuel Nji
Journal:  Glob Health Action       Date:  2019-12-13       Impact factor: 2.640

Review 5.  Third force in the treatment of COVID-19: A systematic review and meta-analysis.

Authors:  Titus Ibekwe; Perpetua Ibekwe; Emmanuel Adebola Orimadegun
Journal:  Ann Med Surg (Lond)       Date:  2021-04-03

Review 6.  COVID-19: Where is the treatment?

Authors:  Bonala Sabeerabi; Sarojamma Vemula; Ramakrishna Vadde; Ganji Purnachandra Nagaraju
Journal:  World J Clin Oncol       Date:  2021-05-24

7.  Perinatal-Neonatal Management of COVID-19 Infection - Guidelines of the Federation of Obstetric and Gynaecological Societies of India (FOGSI), National Neonatology Forum of India (NNF), and Indian Academy of Pediatrics (IAP).

Authors:  Deepak Chawla; Dinesh Chirla; Samir Dalwai; Ashok K Deorari; Atul Ganatra; Alpesh Gandhi; Nandkishor S Kabra; Praveen Kumar; Pratima Mittal; Bakul Jayant Parekh; M Jeeva Sankar; Tanu Singhal; Sindhu Sivanandan; Parikshit Tank
Journal:  Indian Pediatr       Date:  2020-04-01       Impact factor: 1.411

8.  Analysis of COVID-19 clinical trials: A data-driven, ontology-based, and natural language processing approach.

Authors:  Shray Alag
Journal:  PLoS One       Date:  2020-09-30       Impact factor: 3.240

Review 9.  COVID-19 vaccines: The status and perspectives in delivery points of view.

Authors:  Jee Young Chung; Melissa N Thone; Young Jik Kwon
Journal:  Adv Drug Deliv Rev       Date:  2020-12-24       Impact factor: 17.873

10.  Covid-19 pandemic and pregnancy.

Authors:  Satoshi Hayakawa; Shihoko Komine-Aizawa; Gil G Mor
Journal:  J Obstet Gynaecol Res       Date:  2020-08-10       Impact factor: 1.697
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.